DURECT CORP. DL-001
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment… Read more
Market Cap & Net Worth: DURECT CORP. DL-001 (DC8A)
DURECT CORP. DL-001 (F:DC8A) has a market capitalization of $51.00 Million (€49.69 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #21712 globally and #2358 in its home market, demonstrating a -0.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DURECT CORP. DL-001's stock price €1.60 by its total outstanding shares 31054187 (31.05 Million).
DURECT CORP. DL-001 Market Cap History: 2015 to 2025
DURECT CORP. DL-001's market capitalization history from 2015 to 2025. Data shows change from $63.98 Million to $51.00 Million (-1.35% CAGR).
DURECT CORP. DL-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DURECT CORP. DL-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DC8A by Market Capitalization
Companies near DURECT CORP. DL-001 in the global market cap rankings as of March 19, 2026.
Key companies related to DURECT CORP. DL-001 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
DURECT CORP. DL-001 Historical Marketcap From 2015 to 2025
Between 2015 and today, DURECT CORP. DL-001's market cap moved from $63.98 Million to $ 51.00 Million, with a yearly change of -1.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €51.00 Million | +81.82% |
| 2024 | €28.05 Million | +67.62% |
| 2023 | €16.74 Million | -83.05% |
| 2022 | €98.75 Million | +271.02% |
| 2021 | €26.62 Million | -50.59% |
| 2020 | €53.87 Million | -40.91% |
| 2019 | €91.17 Million | +529.96% |
| 2018 | €14.47 Million | -40.96% |
| 2017 | €24.51 Million | -37.33% |
| 2016 | €39.11 Million | -38.86% |
| 2015 | €63.98 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of DURECT CORP. DL-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.00 Million USD |
| MoneyControl | $51.00 Million USD |
| MarketWatch | $51.00 Million USD |
| marketcap.company | $51.00 Million USD |
| Reuters | $51.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.